Diabetes Management

Diabetes affects more than 9% of the US population; approximately 30 million people. Those with diabetes are unable to process blood sugar effectively due to defects in their body’s insulin production or in the way that their insulin functions.

The Diabetes Department at Reliable Respiratory is here to serve every need of our diabetic patients with ease and speed. We have the same great staff, the same location in Norwood, MA, and provide the same exceptional service that you’ve come to expect from Reliable Respiratory.

We offer seamless billing through insurance, and deliver next day on most orders. You’ll never be without the supplies you need with our automatic reorder reminders and our monthly and quarterly supply intervals.

Reliable Respiratory offers a variety of therapies to manage our mutual patients chronic conditions. Utilizing the most advanced equipment and software, Reliable takes a patient-centered approach to delivering positive outcomes and providing outstanding services for the customers we serve.

We offer a variety of Continuous Glucose Monitors, Insulin Pumps and supplies, with standard delivery times between just 1-3 business days. With locations in every New England state, Reliable Respiratory is the local, one-stop shop for all of your
patients’ needs, capable of delivering what they need, when they need it.

Therapeutic CGMs and related supplies are covered by Medicare when all the following coverage criteria are met:

• The beneficiary has diabetes mellitus
• The beneficiary has been using a blood glucose monitor (BGM) and performing frequent (4 or more times a day) testing
• The beneficiary is insulin-treated with multiple (3 or more) daily injections of insulin or a Medicare covered continuous subcutaneous insulin infusion (CSII) pump
• The beneficiary’s insulin treatment regimen requires frequent adjustment by the beneficiary on the basis of BGM or CGM testing results
• Within six (6) months prior to ordering the CGM, the treating practitioner has an in-person visit with the beneficiary to evaluate their diabetes control and determined that criteria (1-4) above are met
• Every six (6) months following the initial prescription of the CGM, the treating practitioner has an in-person visit with the beneficiary to assess adherence to their CGM regimen and diabetes treatment plan.